Semaglutide Injection (Ozempic) for type-2 diabetes was approved by China in 2021
DOI #SleepMedicine #Tirzepatide #ObstructiveSleepApnea #SpringerNature #Research #Pharmacology To view or add a comment, sign in Explore content categories
Some individuals may use it short-term to reach a specific goal, while others may continue treatment longer for ongoing weight management
Over an 18-month treatment course, the cost difference is substantial: Brand-name Ozempic: $17,442 (at $969/month) Compounded semaglutide: $3,582 (at $199/month) Total savings: $13,860 This dramatic price difference makes treatment accessible to people who would otherwise be unable to afford it at brand-name prices, even with good insurance coverage and copays
Compounded tirzepatide from licensed 503A pharmacies is a personalized dual-action weight loss medication that requires careful storage to maintain full strength and safety
Developments in these areas aim not only to reduce symptoms, as current treatment options do, but also to restore thyroid function